124 related articles for article (PubMed ID: 3465575)
1. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
Johnson DC; Joshi RC; Mehta R; Cunnington AR
Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
[TBL] [Abstract][Full Text] [Related]
2. [Long-term treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies with nifedipine. Hemodynamic study over 18 months].
Saadjian A; Philip-Joet F; Vestri R; Arnaud A
Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):197-202. PubMed ID: 2735734
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of acute and chronic effects of nifedipine in patients with secondary pulmonary hypertension].
Dubiel JP; Nikodemowicz M; Zmudka K; Mazurek S; Królikowski T
Kardiol Pol; 1991; 34(5):279-86. PubMed ID: 1921110
[TBL] [Abstract][Full Text] [Related]
4. [Nifedipine in the treatment of chronic cor pulmonale].
Saadjian A; Philip-Joet F; Tran N'guyen A; Arnaud A; Torresani J
Arch Mal Coeur Vaiss; 1986 Jan; 79(1):76-83. PubMed ID: 3085613
[TBL] [Abstract][Full Text] [Related]
5. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M
Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
[TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
Wimmer M; Schlemmer M; Ebner F
Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
[TBL] [Abstract][Full Text] [Related]
8. [Value of nifedipine in respiratory failure related to obstructive chronic bronchitis during treatment over 6 months].
Meurice JC; Boutaud P; Herpin D; Ingrand P; Boita F; Underner M; Patte F
Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):171-7. PubMed ID: 2735732
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
Brownlee JR; Beekman RH; Rosenthal A
Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
[TBL] [Abstract][Full Text] [Related]
10. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration].
Liu Z; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and hemodynamic evaluation of 6-week treatment of pulmonary hypertension in chronic obstructive lung diseases (COLD) with low dose of prazosin].
Lewczuk J; Spikowski J; Sobkowicz-Woźniak B; Porada A; Wrabec K; Trzesicka M; Piszko P; Palka PS; Szczygielski J
Kardiol Pol; 1990; 33(6):358-64. PubMed ID: 2084301
[TBL] [Abstract][Full Text] [Related]
12. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.
Bertoli L; Fusco M; Lo Cicero S; Micallef E; Busnardo I
Postgrad Med J; 1986; 62 Suppl 1():47-51. PubMed ID: 3022273
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study.
Saadjian AY; Philip-Joet FF; Vestri R; Arnaud AG
Eur Respir J; 1988 Aug; 1(8):716-20. PubMed ID: 3069486
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension].
Coulaud JM; Faitg R; Poler F; Rezgui N; Besse B; Lissac J
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():51-6. PubMed ID: 2147835
[TBL] [Abstract][Full Text] [Related]
15. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases using calcium antagonists in an acute trial].
Schauer J; Himmel W; Orschekowski H
Z Gesamte Inn Med; 1989 Jan; 44(2):50-4. PubMed ID: 2650472
[TBL] [Abstract][Full Text] [Related]
16. Decrease in pulmonary artery pressure with slow release nifedipine in Saudi patients with primary pulmonary hypertension.
Ribeiro PA; Sivanandan V; Shaikh A; Chalak W; Zaman L; Duran CM
Rev Port Cardiol; 1991 May; 10(5):413-8. PubMed ID: 1910877
[TBL] [Abstract][Full Text] [Related]
17. The influence of nifedipine (Corinfar) on pulmonary hypertension in chronic obstructive lung disease.
Schauer J; Orschekowski H; Steiniger L; Winkler J; Schilling W; Harzbecker K; Evers H
Z Erkr Atmungsorgane; 1990; 175(3):132-40. PubMed ID: 2127872
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.
Johnson CE; Beekman RH; Kostyshak DA; Nguyen T; Oh DM; Amidon GL
Pediatr Res; 1991 May; 29(5):500-3. PubMed ID: 1896255
[TBL] [Abstract][Full Text] [Related]
20. [Nifedipine treatment of pulmonary hypertension as a complication of chronic obstructive diseases of the lungs].
Paleev NR; Tsa'rkova LN; Uribe-Echevarria EE; Baklykova SN; Novoderezhkina LB
Klin Med (Mosk); 1989 Jun; 67(6):117-20. PubMed ID: 2674536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
